Hollsteen

Tower Semiconductor

We are a pure-play independent specialty foundry, and as such we are dedicated to providing high-value, high-quality, processed wafers to our customers for their end products and end users.

20-F, Apr 30, 2026

Business

How does Tower Semiconductor make money?

No revenue split that adds up to total revenue.

Empty state, nothing estimated.

What is left of every $100?

Of every $100 in revenue, $14 is net income.

Where do customers sit?

No revenue-by-region breakdown in the latest annual report's XBRL data.

In the company’s words ›

“Our foundry processes use chemical materials, chemical processes and other materials and equipment on silicon wafers, based on the design specifications of our customers.”

“As a pure-play foundry, we do not offer products of our own.”

“We currently offer process technology geometries of 0.35, 0.18, 0.16 and 0.13 -micron on 200-mm wafers and 65 nanometer on 300-mm wafers.”

Item 4 · Information on the Company · 20-F · 0001178913-26-002318 · filed Apr 30, 2026

Thesis

Why do people invest?

No filing sentence met the rules.

KPIs

How fast is revenue growing?

Revenue grew 9.1% to $1.6B.

Did the growth reach the shareholder?

Per share, revenue fell 9.0%.

How profitable is it?

12.4% operating margin, down from 13.3%.

How much cash does it make, and where does it go?

Free cash flow was negative: −$48.9M in FY2025.

How strong is the balance sheet?

$235M cash vs $162M debt.

Dependencies

How much revenue hangs on one customer?

One Tower Semiconductor customer: $172M.

Customers, suppliers, stakes and mentions ›

Only what filings state. Anonymous customers stay anonymous.

Largest customers (Tower Semiconductor annual report)

Customer A11% not named · FY2025 · share of total revenue
Customer B7% not named · FY2025 · share of total revenue
“In 2025, 11% of our revenues were generated from NTCJ, 39% of our revenues were derived from an additional seven customers, each of which generated between 4% to 7% of our revenues, and the remaining 50% of our revenues were derived from many other smaller customers.”

20-F · 0001178913-26-002318 · filed Apr 30, 2026 · basis: filing text, verified verbatim

Suppliers named by Tower Semiconductor

Intel“In September 2023, Tower and Intel signed an agreement under which Intel undertook to build a capacity corridor at Tower’s instruction, to enable Intel to manufacture wafers for Tower’s customers at Intel’s 300mm facility in New Mexico, U.S.”
Synopsys“To support these activities, we collaborate with leading design automation providers - including Cadence Design Systems, Synopsys, Siemens EDA, and Keysight Technologies - and license standard cells, I/O, and memory IP from Synopsys, eMemory, and other top suppliers of physical IP.”
Intel“Capacity Corridor Agreement with Intel In September 2023, Tower and Intel signed an agreement under which Intel has committed to build a capacity corridor at Tower’s instructions, in order for Intel to manufacture wafers for Tower’s customers in Intel’s 300mm facility in New Mexico, USA.”

Tower Semiconductor holds stakes in

No stake in a covered company found in SEC filings.

Others name Tower Semiconductor

1 competitor mention (e.g. GlobalFoundries) in covered companies’ filings. Mentions, not confirmed relationships.

Risks

What could go wrong?

4 of 45 risk factors, one per theme.

  • Supply chain and manufacturing
    “Over-demand for our foundry services and/or products may result in operational bottlenecks and a loss of customers and revenues, which may adversely affect our profitability and business.”

    Item 3.D · Risk Factors · 20-F · 0001178913-26-002318 · filed Apr 30, 2026

  • Trade, government policy and geopolitics
    “We are subject to risks related to our international operations.”

    Item 3.D · Risk Factors · 20-F · 0001178913-26-002318 · filed Apr 30, 2026

  • Security, defects and outages
    “Security, cyber and privacy breaches may harm our business and operations.”

    Item 3.D · Risk Factors · 20-F · 0001178913-26-002318 · filed Apr 30, 2026

  • Regulation and legal proceedings
    “From time to time, we are a party to litigation that may require management time and effort.”

    Item 3.D · Risk Factors · 20-F · 0001178913-26-002318 · filed Apr 30, 2026

Who’s invested

Who owns more than 5%?

Price T Rowe Associates Inc /Md/ holds 6.6%.

  • Price T Rowe Associates Inc /Md/6.6%

    13G · as of Mar 31, 2026 · filed May 15, 2026

  • Menora Mivtachim Holdings Ltd.6.17%

    13G/A · as of Dec 31, 2025 · filed Feb 10, 2026

  • Migdal Insurance & Financial Holdings Ltd.5.98%

    13G/A · as of Jun 30, 2026 · filed Jul 23, 2026

  • Harel Insurance Investments & Financial Services Ltd.5.1%

    13G · as of Jun 10, 2026 · filed Jun 15, 2026

  • Phoenix Financial Ltd.5.01%

    13G · as of Jun 5, 2026 · filed Jun 9, 2026

13F holders and insider trades ›

Largest institutional holders, 13F, quarter ending Jun 30, 2026

  • Phoenix Financial Ltd.5.5%

    3.5M shares · 13F filed Aug 11, 2026 · share of 13F-reported

  • BlackRock, Inc.5.2%

    3.3M shares · 13F filed Aug 7, 2026 · share of 13F-reported

  • Vanguard Capital Management LLC5.0%

    3.1M shares · 13F filed Aug 13, 2026 · share of 13F-reported

  • Jane Street Group, LLC4.6%

    2.9M shares · 13F filed Aug 14, 2026 · share of 13F-reported

  • Senvest Management, LLC2.9%

    1.8M shares · 13F filed Aug 14, 2026 · share of 13F-reported

452 13F filers report positions. 13F covers managers with over $100M in US equities; it is not a full shareholder list, and shares are not a percentage of shares outstanding. 3 large filings with inconsistent reported value per share left out.

Insiders, last 12 months (Form 4, open market)

0 purchases · 38 sales · $60.0M sold

Grants, gifts and tax withholding counted separately · window Oct 15, 2025 – Oct 15, 2026

All metrics

All metrics · 33 SEC metrics, FY2016–FY2025
Income statement 10
MetricFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cost of revenue
D&A
Gross profit
Income taxes
Interest expense
Net income
Operating income
Research and development
Revenue
SG&A
Balance sheet 10
MetricFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents
Current liabilities
Current portion of long-term debtnot reportednot reported
Equity
Equity incl. NCI
Long-term debtnot reportednot reportednot reportednot reportednot reportednot reported
Short-term debt (balance sheet line)not reportednot reportednot reportednot reportednot reportednot reported
Total assets
Total debt calc.not reportednot reportednot reportednot reportednot reportednot reported
Total liabilities & equity
Cash flow 5
MetricFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Capex
Free cash flow calc.
Interest paid
Operating cash flow
Stock-based compensation
Per share & shares 4
MetricFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
EPS basic
EPS diluted
Wtd. shares basic
Wtd. shares diluted
Other 4
MetricFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
NCI income
Other income (incl. interest)
Pretax income
Total liabilities